Cargando…

Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges

Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy in adults, and it is associated with local D4Z4 chromatin relaxation, mostly via the contraction of the D4Z4 macrosatellite repeat array on chromosome 4q35. In this study, we aimed to investigate the use of Op...

Descripción completa

Detalles Bibliográficos
Autores principales:	Efthymiou, Stephanie, Lemmers, Richard J. L. F., Vishnu, Venugopalan Y., Dominik, Natalia, Perrone, Benedetta, Facchini, Stefano, Vegezzi, Elisa, Ravaglia, Sabrina, Wilson, Lindsay, van der Vliet, Patrick J., Mishra, Rinkle, Reyaz, Alisha, Ahmad, Tanveer, Bhatia, Rohit, Polke, James M., Srivastava, Mv Padma, Cortese, Andrea, Houlden, Henry, van der Maarel, Silvère M., Hanna, Michael G., Bugiardini, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669274/ https://www.ncbi.nlm.nih.gov/pubmed/38002249 http://dx.doi.org/10.3390/biom13111567

Ejemplares similares

Facioscapulohumeral dystrophy: the path to consensus on pathophysiology
por: Tawil, Rabi, et al.
Publicado: (2014)

Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy
por: Greco, Anna, et al.
Publicado: (2020)

Facioscapulohumeral Dystrophy in Childhood: A Nationwide Natural History Study
por: Goselink, Rianne J.M., et al.
Publicado: (2018)

Ophthalmological findings in facioscapulohumeral dystrophy
por: Goselink, Rianne J M, et al.
Publicado: (2019)

Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene
por: Snider, Lauren, et al.
Publicado: (2010)

Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy in Patients Clinically Suspected of FSHD Using Optical Genome Mapping
por: Guruju, Naga M., et al.
Publicado: (2023)

Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies
por: Statland, Jeffrey M., et al.
Publicado: (2015)

Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy
por: Šikrová, Darina, et al.
Publicado: (2021)

A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy
por: Feng, Qing, et al.
Publicado: (2015)

DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy
por: Thijssen, Peter E, et al.
Publicado: (2014)

Determining the role of sarcomeric proteins in facioscapulohumeral muscular dystrophy: a study protocol
por: Lassche, Saskia, et al.
Publicado: (2013)

Profiling Serum Antibodies Against Muscle Antigens in Facioscapulohumeral Muscular Dystrophy Finds No Disease-Specific Autoantibodies
por: Greco, Anna, et al.
Publicado: (2021)

Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD)
por: Goselink, Rianne J. M., et al.
Publicado: (2016)

Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy
por: Bouwman, Linde F., et al.
Publicado: (2021)

Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers
por: van den Heuvel, Anita, et al.
Publicado: (2022)

DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy
por: Shadle, Sean C., et al.
Publicado: (2017)

Molecular diagnosis and next generation gene sequencing in neuromuscular clinical practice
por: van der Maarel, Silvère
Publicado: (2013)

Evaluation of blood gene expression levels in facioscapulohumeral muscular dystrophy patients
por: Signorelli, M., et al.
Publicado: (2020)

Optical Genome Mapping Enables Detection and Accurate Sizing of RFC1 Repeat Expansions
por: Facchini, Stefano, et al.
Publicado: (2023)

Genome-wide analysis of macrosatellite repeat copy number variation in worldwide populations: evidence for differences and commonalities in size distributions and size restrictions
por: Schaap, Mireille, et al.
Publicado: (2013)

Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2
por: Lemmers, Richard J.L.F., et al.
Publicado: (2012)

DUX4 expression in cancer induces a metastable early embryonic totipotent program
por: Smith, Andrew A., et al.
Publicado: (2023)

Diabetic Amyotrophy (Bruns-Garland Syndrome): A Narrative Review
por: Agarwal, Ayush, et al.
Publicado: (2022)

Impact of Tele-Neuromuscular Clinic on the Accessibility of Care for Patients with Inherited Neuromuscular Disorders during COVID-19 Pandemic in India
por: Reyaz, Alisha, et al.
Publicado: (2022)

Use of Social Media in Stroke: A Systematic Review
por: Garg, Divyani, et al.
Publicado: (2023)

Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy
por: van der Kooi, E. L., et al.
Publicado: (2007)

Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4
por: Balog, Judit, et al.
Publicado: (2015)

Clinodactyly – A Clinical Clue to Diagnose a Hereditary Periodic Paralysis
por: Parihar, Jasmine, et al.
Publicado: (2020)

The socioeconomic burden of facioscapulohumeral muscular dystrophy
por: Blokhuis, Anna M., et al.
Publicado: (2021)

Specific Loss of Histone H3 Lysine 9 Trimethylation and HP1γ/Cohesin Binding at D4Z4 Repeats Is Associated with Facioscapulohumeral Dystrophy (FSHD)
por: Zeng, Weihua, et al.
Publicado: (2009)

Facioscapulohumeral muscular dystrophy—Reproductive counseling, pregnancy, and delivery in a complex multigenetic disease
por: Vincenten, Sanne C. C., et al.
Publicado: (2021)

Characterizing the face in facioscapulohumeral muscular dystrophy
por: Loonen, T. G. J., et al.
Publicado: (2020)

Natural History of Facioscapulohumeral Dystrophy in Children: A 2-Year Follow-up
por: Dijkstra, Jildou N., et al.
Publicado: (2021)

Treatment of facioscapulohumeral muscular dystrophy with Denosumab
por: Lefkowitz, Stanley S., et al.
Publicado: (2012)

Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy
por: Vera, Kathryn, et al.
Publicado: (2020)

Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
por: Anselmo, Miguel, et al.
Publicado: (2022)

Innovations in Acute Stroke Reperfusion Strategies
por: Vishnu, Venugopalan Y., et al.
Publicado: (2019)

Ticagrelor in Stroke Prevention New Wine in an Old Bottle?
por: Padma Srivastava, M. V., et al.
Publicado: (2022)

Quantifying Quality of Life after Stroke
por: Padma Srivastava, M. V., et al.
Publicado: (2022)

Conduct of Virtual Neurology DM Final Examination during COVID-19 Pandemic
por: Rajan, Roopa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dm817cc6an0g9t7gd9pk7rjlqf